How to Strike a Deal in Oncology: Innovative Partnering Approaches Across Biotech and Pharma

Tackling a problem like cancer requires both the ingenuity of small biotech players and the expertise, and financial resources, of pharma heavyweights. But how can the two come together to create effective partnerships in this crowded and complex field? This session will bring together business development executives from both biotech and pharma to weigh in on the specific considerations that must go into deal-making in oncology. Panelists will discuss what companies look for in a partner and how it connects to their corporate strategy; the evolution of deal structures in recent years and impact of the current market; and what types of platforms or programs are attractive partnering options.